China approves Nuvectis drug ciprocopan for PNH treatment
Go back to China approves Nuvectis drug ciprocopan for PNH treatment| (NASDAQ: NVCT) | Delayed: 20.52 -0.07 (0.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $20.59 | 52 Week High | $ | |||
| Open | $20.63 | 52 Week Low | $ | |||
| Day High | $21.72 | P/E | N/A | |||
| Day Low | $19.94 | EPS | $ | |||
| Volume | 146,500 | |||||



